Attenuated familial adenomatous polyposis

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Dec 21, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Status:
Completed
Last Changed:
Jun 17, 2016
First Changed:
Aug 24, 2010
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
ErlotinibSulindacPlacebo APlacebo B
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Status:
Active, not recruiting
Last Changed:
May 18, 2022
First Changed:
Nov 11, 2016
Disease(s):
APC Gene Mutation
Intervention(s):
Erlotinib HydrochlorideLaboratory Biomarker Analysis

Connect. Empower. Inspire.